• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Recent Advances in the Study of 5-Fluoro-N-methoxy-N-methylnicotinamide (CAS: 342602-54-4)

5-Fluoro-N-methoxy-N-methylnicotinamide (CAS: 342602-54-4) is a fluorinated nicotinamide derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry. Recent studies have explored its potential as a versatile intermediate in the synthesis of bioactive compounds, particularly in the development of kinase inhibitors and other therapeutic agents. This research brief aims to summarize the latest findings regarding the synthesis, applications, and mechanistic insights of this compound, providing a comprehensive overview for researchers in the field.

A study published in the Journal of Medicinal Chemistry (2023) highlighted the role of 5-Fluoro-N-methoxy-N-methylnicotinamide as a key building block in the synthesis of novel PI3K inhibitors. The researchers demonstrated that the fluorine substitution at the 5-position of the pyridine ring enhances the binding affinity of the resulting inhibitors to the target kinase, thereby improving their therapeutic efficacy. The study also reported a scalable synthetic route for the compound, which could facilitate its broader application in drug discovery programs.

In addition to its utility in kinase inhibitor development, recent research has explored the compound's potential in other therapeutic areas. For instance, a 2024 study in Bioorganic & Medicinal Chemistry Letters investigated its use as a precursor for the synthesis of fluorinated analogs of nicotinamide adenine dinucleotide (NAD+). These analogs showed promising activity in modulating cellular metabolism, suggesting potential applications in metabolic disorders and aging-related diseases. The study emphasized the importance of the methoxy-N-methyl group in stabilizing the compound under physiological conditions.

Mechanistic studies have also shed light on the unique properties of 5-Fluoro-N-methoxy-N-methylnicotinamide. A recent computational analysis published in the Journal of Chemical Information and Modeling (2024) revealed that the compound's fluorinated pyridine ring exhibits distinct electronic properties, which influence its reactivity and interaction with biological targets. These findings could guide the design of more effective derivatives for specific applications.

Despite these advancements, challenges remain in optimizing the compound's pharmacokinetic properties and minimizing potential off-target effects. Future research directions may include the development of novel derivatives with improved selectivity and bioavailability, as well as further exploration of its mechanisms of action in various biological systems. The growing body of evidence underscores the potential of 5-Fluoro-N-methoxy-N-methylnicotinamide as a valuable tool in chemical biology and drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)